Mechanism of Action

 
  • AmLexin™ prevents proteoglycan degradation by suppressing MMPs and inflammatory cytokines
  • Having potent anti-oxidant benefit, it specifically neutralizes superoxide anion known to cause joint wear and tear
  • It helps protect joints from natural wear and tear, effectively inhibiting cartilage catabolic pathways by modulating Cox-1, Cox-2, and 5-Lox enzyme activity

Key Pointers

 
  • Alleviates joint discomfort and stiffness
  • Provides protection for joint cartilage
  • Enhance flexibility and physical function
  • Not only eases pain but also promotes long-term joint health with utmost safety
  • Patented

Clinical Findings

 
  • In a clinical study on subjects with knee osteoarthritis, AmLexin™ at 400mg is clinically proven to reduce cartilage degradation significantly better than Glucosamine 1500mg and Chondroitin 1200mg
  • Proven significantly better at reducing uCTX-II, a type II collagen degradation biomarker by 8.9%
  • Proven to support exercise recovery and reduce delayed onset of muscular soreness (DOMS) in a second clinical trial, on subjects performing strenous sport activity
  • AmLexin™ has been shown to be effective in an ex vivo GAG assay, at reducing Glycosaminoglycan (GAG) released by articular cartilage

Dosage Forms

  • Tablets

  • Capsules